0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Research Letters |  July 09, 2012
Safety Against Cervical Precancer and Cancer Following Negative Human Papillomavirus and Papanicolaou Test Results in Human Immunodeficiency Virus–Infected Women
Philip E. Castle, PhD, MPH; Barbara Fetterman, SCT(ASCP); Nancy Poitras, PMP; et al.
Arch Intern Med. 2012;172(13):1041-1043. doi:10.1001/archinternmed.2012.1744.
Invited Commentary |  June 14, 2010
Rightsizing Cervical Cancer Screening:  Comment on “Cervical Cancer Screening With Both Human Papillomavirus and Papanicolaou Testing vs Papanicolaou Testing Alone”
George F. Sawaya, MD
Arch Intern Med. 2010;170(11):985-986. doi:10.1001/archinternmed.2010.133.
Original Investigation |  June 14, 2010 FREE
Cervical Cancer Screening With Both Human Papillomavirus and Papanicolaou Testing vs Papanicolaou Testing Alone:  What Screening Intervals Are Physicians Recommending?
Mona Saraiya, MD, MPH; Zahava Berkowitz, MSc, MSPH; K. Robin Yabroff, PhD, MBA; et al.
Arch Intern Med. 2010;170(11):977-986. doi:10.1001/archinternmed.2010.134.
Original Investigation |  September 22, 2008 FREE
Trade-offs in Cervical Cancer Prevention:  Balancing Benefits and Risks
Natasha K. Stout, PhD; Jeremy D. Goldhaber-Fiebert, PhD; Jesse D. Ortendahl, BS; et al.
Arch Intern Med. 2008;168(17):1881-1889. doi:10.1001/archinte.168.17.1881.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
Editorial  |  May 01, 2013
HPV Vaccination:  Too Soon for 2 Doses?
Jessica A. Kahn, MD, MPH; David I. Bernstein, MD, MA
JAMA
Original Contribution  |  May 01, 2013
Immunogenicity of 2 Doses of HPV Vaccine in Younger Adolescents vs 3 Doses in Young Women:  A Randomized Clinical Trial
Simon R. M. Dobson, MD; Shelly McNeil, MD; Marc Dionne, MD; et al.
JAMA Dermatology
Correspondence  |  Mar 2013
Complete Resolution of Chronic Multiple Verruca Vulgaris Treated With Quadrivalent Human Papillomavirus Vaccine
Benjamin S. Daniel, BA, BCom, MBBS; Dedee F. Murrell, BMBCh, MD, FACD
JAMA Otolaryngology–Head & Neck Surgery
Original Article  |  Dec 2012
Predicting HPV Status in Head and Neck Cancer:  The Predictive Value of Sociodemographic and Disease Characteristics
J. Kenneth Byrd, MD; Christina S. T. Wilhoit, CCRP; M. Taylor Fordham, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems